Tuli Gerdi, Munarin Jessica, Biga Anna, Quaglino Francesco, Carbonaro Giulia, De Sanctis Luisa
Department of Public Health and Pediatrics, University of Turin, 10126 Turin, Italy.
Department of Pediatric Endocrinology, Regina Margherita Children's Hospital, 10126 Turin, Italy.
J Clin Med. 2025 Aug 29;14(17):6112. doi: 10.3390/jcm14176112.
Thyroid nodules are rare in the pediatric population but carry a higher malignancy risk compared to adults. Evaluation and management of cytologically indeterminate nodules vary considerably between institutions and countries. The aim was to systematically review current evidence on the management of indeterminate thyroid nodules in the pediatric population. A systematic review of the literature was conducted, focusing on cytological classification systems, surgical strategies, and the use of ancillary tools such as molecular testing. Most studies (42.9%) recommend lobectomy for indeterminate thyroid nodules in children; however, considerable heterogeneity in management strategies was observed among institutions. This variability precluded the possibility of conducting a meta-analysis of surgical outcomes. Additionally, a lack of pediatric-specific risk of malignancy (ROM) data for the British Thyroid Association (BTA) and SIAPEC cytological classification systems was noted. We propose the development of a pediatric-specific, multiparametric risk stratification model that incorporates clinical features, biochemical markers, ultrasound characteristics, cytological classification, and molecular profiling. This comprehensive score could help standardize the management of indeterminate thyroid nodules in children and guide clinical decision-making, ranging from observation to total thyroidectomy. Prospective validation in multicenter pediatric cohorts is essential to confirm its clinical utility.
甲状腺结节在儿科人群中较为罕见,但与成人相比,其恶性风险更高。各机构和国家对细胞学检查结果不确定的结节的评估和管理差异很大。目的是系统评价目前关于儿科人群中不确定甲状腺结节管理的证据。对文献进行了系统回顾,重点关注细胞学分类系统、手术策略以及分子检测等辅助工具的使用。大多数研究(42.9%)建议对儿童不确定甲状腺结节进行甲状腺叶切除术;然而,各机构在管理策略上存在相当大的异质性。这种变异性排除了对手术结果进行荟萃分析的可能性。此外,还注意到英国甲状腺协会(BTA)和意大利甲状腺和内分泌外科学会(SIAPEC)细胞学分类系统缺乏儿科特异性的恶性风险(ROM)数据。我们建议开发一种儿科特异性的多参数风险分层模型,该模型纳入临床特征、生化标志物、超声特征、细胞学分类和分子谱分析。这个综合评分有助于规范儿童不确定甲状腺结节的管理,并指导临床决策,范围从观察到全甲状腺切除术。在多中心儿科队列中进行前瞻性验证对于确认其临床实用性至关重要。